Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prestige Consumer Healthcare (PBH) Gross Margin (2016 - 2025)

Historic Gross Margin for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to 55.52%.

  • Prestige Consumer Healthcare's Gross Margin rose 500.0% to 55.52% in Q4 2025 from the same period last year, while for Dec 2025 it was 56.12%, marking a year-over-year increase of 10000.0%. This contributed to the annual value of 55.76% for FY2025, which is 2800.0% up from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Gross Margin of 55.52% as of Q4 2025, which was up 500.0% from 55.3% recorded in Q3 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Gross Margin ranged from a high of 59.07% in Q2 2021 and a low of 53.79% during Q1 2023
  • For the 5-year period, Prestige Consumer Healthcare's Gross Margin averaged around 55.99%, with its median value being 55.71% (2022).
  • As far as peak fluctuations go, Prestige Consumer Healthcare's Gross Margin tumbled by -24200bps in 2023, and later surged by 25300bps in 2025.
  • Quarter analysis of 5 years shows Prestige Consumer Healthcare's Gross Margin stood at 56.49% in 2021, then dropped by -3bps to 54.59% in 2022, then rose by 2bps to 55.86% in 2023, then decreased by -1bps to 55.47% in 2024, then increased by 0bps to 55.52% in 2025.
  • Its Gross Margin stands at 55.52% for Q4 2025, versus 55.3% for Q3 2025 and 56.24% for Q2 2025.